InvestorsHub Logo
Followers 4
Posts 479
Boards Moderated 0
Alias Born 01/03/2015

Re: To infinity and beyond! post# 236211

Sunday, 08/05/2018 9:09:36 AM

Sunday, August 05, 2018 9:09:36 AM

Post# of 403025
Understood.

The study’s main goal was to provide indications of efficacy, safety and tolerability upon treating patients with mild to moderate plaque psoriasis via oral delivery, per the company.

You're mentioning knockout product.
And you mention P was not impressive at all vs placebo.

The company did not intend the to show knockout results. I believe they are trying to prove a pill form of psoriasis treatment that can work earlier and be safer. Not going for homerun. Per company, patients who received any dose of Prurisol, regardless of the treatment arm, had a 1-point improvement (using the IGA scoring system) at a higher rate than that of patients in the placebo arm. This is another clear indication of the drug’s efficacy. 
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News